BioCardia Probability of Future Stock Price Finishing Over 0.40
BioCardia's future price is the expected price of BioCardia instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of BioCardia performance during a given time horizon utilizing its historical volatility. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Please specify BioCardia's target price for which you would like BioCardia odds to be computed.
BioCardia |
BioCardia Target Price Odds to finish over 0.40
The tendency of BioCardia Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 0.40 or more in 90 days |
| 0.00 | 90 days | 0.40 | close to zero percent |
Based on a normal probability distribution, the odds of BioCardia to move over $ 0.40 or more in 90 days from now is close to zero percent (This BioCardia probability density function shows the probability of BioCardia Stock to fall within a particular range of prices over 90 days) . Probability of BioCardia price to stay between its current price of $ 0.00 and $ 0.40 at the end of the 90-day period is close to 99 .
Assuming the 90 days horizon the stock has the beta coefficient of 5.02 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, BioCardia will likely underperform. Moreover BioCardia has an alpha of 1.1168, implying that it can generate a 1.12 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). BioCardia Price Density |
| Price |
Predictive Modules for BioCardia
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioCardia. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BioCardia Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. BioCardia is not an exception. The market had few large corrections towards the BioCardia's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioCardia, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioCardia within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.12 | |
β | Beta against Dow Jones | 5.02 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.06 |
BioCardia Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioCardia for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioCardia can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BioCardia is not yet fully synchronised with the market data | |
| BioCardia has some characteristics of a very speculative penny stock | |
| BioCardia has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 477 K. Net Loss for the year was (11.57 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BioCardia generates negative cash flow from operations |
BioCardia Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BioCardia Stock often depends not only on the future outlook of the current and potential BioCardia's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioCardia's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 21.2 M | |
| Cash And Short Term Investments | 1.1 M | |
| Shares Float | 1.2 M |
BioCardia Technical Analysis
BioCardia's future price can be derived by breaking down and analyzing its technical indicators over time. BioCardia Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BioCardia. In general, you should focus on analyzing BioCardia Stock price patterns and their correlations with different microeconomic environments and drivers.
BioCardia Predictive Forecast Models
BioCardia's time-series forecasting models is one of many BioCardia's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BioCardia's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about BioCardia
Checking the ongoing alerts about BioCardia for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BioCardia help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| BioCardia is not yet fully synchronised with the market data | |
| BioCardia has some characteristics of a very speculative penny stock | |
| BioCardia has a very high chance of going through financial distress in the upcoming years | |
| The company reported the revenue of 477 K. Net Loss for the year was (11.57 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| BioCardia generates negative cash flow from operations |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in BioCardia Stock
If you are still planning to invest in BioCardia check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioCardia's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |